Treatment Approach in Stage III NSCLC

 

J

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

By John Conibear 2 Videos
1,818 views
March 8, 2023
0 Comments
Login to view comments. Click here to Login
Treatment Approach in Stage III NSCLC
09:40
John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

10:51
Winship Cancer Institute - Emory University

Optimising Chemoradiation to Reduce Pneumonitis Risk in Patients Wit…

Feat. N. McCall
10:47
Giulia Pasello

The Multidisciplinary Approach in Stage III NSCLC Over 10 Years: Fro…

12:40
Yale Cancer Center

Consolidation IO Following CRT in Stage III NSCLC

Feat. H. Park
15:01
OncoAlert

Radiation Oncology 2022: Advances in NSCLC

Feat. H. Willers, A. Wisdom
09:13
Federico Cappuzzo

New Options in Stage III NSCLC

12:41
Lung Cancer Europe (LuCE)

Unresectable Stage III NSCLC: Key Findings

Feat. J. Naidoo
14:23
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Updates on the Use of Consolidation IO in NSCLC Based on Biomarker S…

Feat. E. Vokes
41:16
Total Health

2023 Case-Based Clinical Updates in Lung Cancer

Feat. N. Seetharamu
22:46
2023 Texas Lung Cancer Conference Coverage

When Is PD(L)1 Monotherapy for NSCLC Enough?

Feat. S. Gadgeel
23:36
CHEST 2022 Coverage

Immune Checkpoint Inhibitor Pneumonitis in Lung Cancer

Feat. J. Possick
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
37:21
Moffitt Cancer Center

Managing Immunotherapy-Related Adverse Events

Feat. K. Hendrix, S. Logan
17:57
2023 Texas Lung Cancer Conference Coverage

Advantages of Chemoimmunotherapy for NSCLC

Feat. M. Johnson
07:58
Janeesh Sekkath Veedu

Survival Outcomes of Surgery-Based Treatment or Definitive CRT With …

20:34
2023 Texas Lung Cancer Conference Coverage

Current Role of Adjuvant IO in NSCLC

Feat. J. Donington
16:36
Fox Chase Cancer Center

Adjuvant Therapy for Resectable NSCLC: State of the Art

Feat. M. Edelman
08:55
Insights from 2023 ASCO® Annual Meeting

Surgical Aspects in the Treatment of Locally Advanced NSCLC

Feat. G. Veronesi
08:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ARC-7: Randomized Phase 2 Study of Domvan…

Feat. M. Johnson